Tom Li Stephen

Title: Tom Li Stephen: Innovator in Bicyclic Peptide Ligands

Introduction

Tom Li Stephen is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of biochemistry, particularly in the development of peptide ligands. His work focuses on innovative solutions for medical applications, showcasing his expertise and dedication to advancing science.

Latest Patents

Tom Li Stephen holds a patent for "Bicyclic peptide ligands specific for OX40." This invention relates to polypeptides that are covalently bound to molecular scaffolds, allowing for the formation of two or more peptide loops between attachment points. The peptides described in this patent are designed to bind to OX40, which plays a crucial role in immune response. The invention also encompasses multimeric binding complexes that function as agonists of OX40. Additionally, it includes drug conjugates that incorporate these peptides and complexes, aimed at preventing, suppressing, or treating diseases mediated by OX40.

Career Highlights

Tom Li Stephen is associated with Bicycletx Limited, where he continues to innovate and develop new technologies. His work has positioned him as a key figure in his field, contributing to advancements that have the potential to impact therapeutic strategies.

Collaborations

Tom collaborates with talented individuals such as Kevin McDonnell and Nicholas Keen. Their combined expertise fosters a productive environment for innovation and research.

Conclusion

Tom Li Stephen is a distinguished inventor whose work on bicyclic peptide ligands has the potential to transform therapeutic approaches in medicine. His contributions reflect a commitment to scientific advancement and innovation.